Journal of Clinical Laboratory Analysis

Papers
(The H4-Index of Journal of Clinical Laboratory Analysis is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
550
Misdiagnosis of a patient with congenital dysfibrinogenemia: A case report and literature review306
Diagnostic value of total testosterone and free androgen index measured by LCMS/MS for PCOS and insulin resistance130
Downregulation of MMP1 functions in preventing perineural invasion of pancreatic cancer through blocking the NT‐3/TrkC signaling pathway73
Hsa_hsa_circ_0081069 promotes the progression of colorectal cancer through sponging miR‐665 and regulating E2F3 expression61
The usefulness of the estimated average glucose/fasting blood glucose ratio for pancreatic β‐cell function assessment in hyperglycemia during health checkups59
Validation of high concentrated thrombin time assay for unfractionated heparin monitoring59
CEBPB regulates the bile acid receptor FXR to accelerate colon cancer progression by modulating aerobic glycolysis52
Proxalutamide for the treatment of COVID‐19 rebound following Paxlovid treatment: Report of four cases and review of the literature48
Corrigendum48
Deciphering the Role of Calcium Signaling Pathway‐Associated Single Nucleotide Variants in Susceptibility to Hypertension47
Issue Information47
A Large‐Scale Retrospective Study of Serum Des‐Gamma‐Carboxy Prothrombin as a Diagnostic Marker of HCC: Effect of Liver Function on Specificity44
Aberrant blood MALT1 and its relevance with multiple organic dysfunctions, T helper cells, inflammation, and mortality risk of sepsis patients39
Rapid detection of the irinotecan‐related UGT1A1*28 polymorphism by asymmetric PCR melting curve analysis using one fluorescent probe39
Analytical and clinical evaluation of the light‐initiated chemiluminescent assays for measurement of human thyroid hormones39
A dilute‐and‐shoot liquid chromatography–tandem mass spectrometry method for urinary 18‐hydroxycortisol quantification and its application in establishing reference intervals38
Associations of CYP2B6 genetic polymorphisms with Hirschsprung’s disease in a southern Chinese population34
Soluble Triggering Receptors on Myeloid Cells‐1 Could Be a Potential Biomarker for Disease Activity in Familial Mediterranean Fever33
Performance evaluation of the i‐Smart 300E cartridge for point‐of‐care electrolyte measurement in serum and plasma32
Mutation patterns and prognostic analysis of BRAF/KRAS/PIK3CA in colorectal cancer31
Development of six immune‐related lncRNA signature prognostic model for smoking‐positive lung adenocarcinoma31
A Narrative Review of Bedaquiline and Delamanid: New Arsenals Against Multidrug‐Resistant and Extensively Drug‐Resistant Mycobacterium tuberculosis30
Comorbidities and mortality rate in COVID‐19 patients with hematological malignancies: A systematic review and meta‐analysis30
Exploration of the Clinical Effect of Different Autotransfusion Methods on Patients With Femoral Shaft Fracture Surgery30
Evaluation of a new point‐of‐care quantitative reverse transcription polymerase chain test for detecting severe acute respiratory syndrome coronavirus 229
JNK pathway‐associated phosphatase illustrates low expression and negative correlations with inflammation, disease activity, and T‐helper 17 cells in inflammatory bowel disease children29
CYP2S1 rs338599 polymorphism confers reduced risk to anti‐tuberculosis drug‐induced liver injury and may be a novel marker for its risk prediction29
Simultaneous point‐of‐care testing of blood lipid profile and glucose: Performance evaluation of the GCare Lipid Analyzer29
Evaluation of chromosomal abnormalities in the postnatal cohort: A single‐center study on 14,242 patients29
29
The lower expression of circulating miR‐210 and elevated serum levels of HIF‐1α in ischemic stroke; Possible markers for diagnosis and disease prediction29
Ultra‐Sensitive Quantification of Indoxyl Sulfate and 3‐Carboxy‐4‐Methyl‐5‐Propyl‐2‐Furanpropanoic Acid in Plasma Using Ultra‐Performance Liquid Chromatography Coupled to Quadrupole Time‐of‐Flight Mas29
0.15550303459167